1,986 results on '"Van Hemelrijck, Mieke"'
Search Results
202. Limb volume reduction and infection outcomes following vascularized lymph node transfer for cancer treatment-related lymphoedema: a systematic review and meta-analysis
203. Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial
204. Introduction to Cancer Epidemiology
205. Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study
206. sj-docx-1-uro-10.1177_20514158211065949 ��� Supplemental material for MRI-based nomogram for the prediction of prostate cancer diagnosis: A multi-centre validated patient���physician decision tool
207. Additional file 1 of Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19
208. Erratum to 'Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial' [Eur Urol 2022;81:385-393]
209. Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire
210. Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study
211. Tobacco use and bladder cancer patterns in three western European countries
212. Trends in Lung Cancer Death Rates in Belgium and The Netherlands: a Systematic Analysis of Temporal Patterns
213. Impact of the COVID‐19 pandemic on urological cancers: The surgical experience of two cancer hubs in London and Milan
214. MRI-based nomogram for the prediction of prostate cancer diagnosis: A multi-centre validated patient–physician decision tool
215. The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy’s Cancer Centre
216. Prostate Cancer Interview Guide
217. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
218. Global cancer research in the post-pandemic world
219. Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
220. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
221. Impact of the COVID-19 Pandemic on Cancer Researchers in 2020: A Qualitative Study of Events to Inform Mitigation Strategies
222. Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study
223. Sex differences and survival of neuroendocrine neoplasia in England 2012-2018
224. The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer
225. Incidence, prevalence of survival of neuroendocrine neoplasia in England 1995-2018
226. Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
227. Association of Inflammatory Markers and Blood Cell Counts and the Risk of Leukemia in the Swedish Amoris Cohort
228. Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS) - Composition of a Prognostic FCM-Score for Overall Survival
229. Causes of death in men with localized prostate cancer: a nationwide, population-based study
230. Female sexual function in bladder cancer: A review of the evidence.
231. Developing a consensus statement for psychosocial support in active surveillance for prostate cancer.
232. Safe delivery of systemic anti‐cancer treatment for skin cancers during the COVID‐19 pandemic.
233. An investigation into the relationship between statins and cancer using population-based data
234. Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
235. Cancer and COVID-19 vaccines: a complex global picture
236. Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging
237. “Something Good Has to Come Out of the Horror”: A Qualitative Examination of Cancer Survivors' Attitudes Towards Participation in Research During the First Year of the COVID-19 Pandemic
238. Predicting response to neoadjuvant chemotherapy in patients with oesophageal adenocarcinoma
239. Development and outcomes of a virtual triage pathway for cancer diagnosis in vague symptom patients.
240. Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review
241. The Current Evidence for Factors that Influence Treatment Decision Making in Localized Kidney Cancer: A Mixed Methods Systematic Review
242. Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21)
243. PD58-04 EFFECT OF SIMULATION-BASED TRAINING ON SURGICAL PROFICIENCY AND PATIENT OUTCOMES: THE SIMULATE RANDOMIZED CONTROLLED TRIAL
244. PD13-07 EVALUATING PATIENT-REPORTED OUTCOMES MEASURES (PROMS) FOR LOCALISED PROSTATE CANCER: A SYSTEMATIC REVIEW USING THE CONSENSUS-BASED STANDARD FOR THE SELECTION OF HEALTH MEASUREMENT INSTRUMENTS (COSMIN) METHODOLOGY
245. Providing a Framework for Meaningful Patient Involvement in Clinical Practice Guideline Development and Implementation
246. The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer
247. 646 PREDICTING RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH OESOPHAGEAL ADENOCARCINOMA
248. ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI
249. 674 TRANSITION FROM ESOPHAGECTOMY TO ENDOSCOPIC THERAPY FOR EARLY ESOPHAGEAL CANCER
250. Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy: A longitudinal study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.